Get started
Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsBondsETFs

ISI chart


Full chart

ISI upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.60 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.49 EUR
Net income (FY)
‪−438.45 M‬ EUR
Revenue (FY)
‪681.15 M‬ EUR
Shares float
‪158.19 M‬
Beta (1Y)
1.06

Employees


Employees (FY)
‪1.07 K‬
Change (1Y)
+142 +15.32%
Revenue / Employee (1Y)
‪637.18 K‬ EUR
Net income / Employee (1Y)
‪−410.15 K‬ EUR

About Ionis Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Brett P. Monia
Website
ionis.com
Headquarters
Carlsbad
Founded
1989
ISIN
US4622221004
FIGI
BBG00FGX78P4
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Check out other big names from the same industry as ISI.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ISI news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ISI highest yielding bonds


IONS5397611
Ionis Pharmaceuticals, Inc. 0.0% 01-APR-2026
Yield to maturity
—
Maturity date
Apr 1, 2026
IONS5835891
Ionis Pharmaceuticals, Inc. 1.75% 15-JUN-2028
Yield to maturity
—
Maturity date
Jun 15, 2028

See all ISI bonds 

ETFs with ISI exposure


VTI
Vanguard Total Stock Market ETF
Weight
0.01%
Market value
‪203.38 M‬
USD
VB
Vanguard Small-Cap ETF
Weight
0.10%
Market value
‪156.85 M‬
USD
XBI
SPDR S&P BIOTECH ETF
Weight
1.93%
Market value
‪120.27 M‬
USD
VBK
Vanguard Small-Cap Growth ETF
Weight
0.22%
Market value
‪87.58 M‬
USD
VXF
Vanguard Extended Market ETF
Weight
0.09%
Market value
‪72.75 M‬
USD
IWP
iShares Russell Mid-Cap Growth ETF
Weight
0.33%
Market value
‪68.65 M‬
USD
IBB
iShares Biotechnology ETF
Weight
1.06%
Market value
‪67.64 M‬
USD
SCHA
Schwab U.S. Small-Cap ETF
Weight
0.29%
Market value
‪54.28 M‬
USD
ARKG
ARK Genomic Revolution ETF
Weight
3.58%
Market value
‪44.60 M‬
USD
IWF
iShares Russell 1000 Growth ETF
Weight
0.03%
Market value
‪39.60 M‬
USD
IWR
iShares Russell Midcap ETF
Weight
0.09%
Market value
‪39.49 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of ISI is 61.38 EUR — it has increased by 1.26% in the past 24 hours. Watch Ionis Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Ionis Pharmaceuticals, Inc. stocks are traded under the ticker ISI.
ISI stock has risen by 2.79% compared to the previous week, the month change is a 13.08% rise, over the last year Ionis Pharmaceuticals, Inc. has showed a 74.72% increase.
We've gathered analysts' opinions on Ionis Pharmaceuticals, Inc. future price: according to them, ISI price has a max estimate of 82.56 EUR and a min estimate of 39.56 EUR. Watch ISI chart and read a more detailed Ionis Pharmaceuticals, Inc. stock forecast: see what analysts think of Ionis Pharmaceuticals, Inc. and suggest that you do with its stocks.
ISI reached its all-time high on Mar 7, 2018 with the price of 99.65 EUR, and its all-time low was 18.63 EUR and was reached on May 27, 2016. View more price dynamics on ISI chart.
See other stocks reaching their highest and lowest prices.
ISI stock is 2.48% volatile and has beta coefficient of 1.06. Track Ionis Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Ionis Pharmaceuticals, Inc. there?
Today Ionis Pharmaceuticals, Inc. has the market capitalization of ‪9.72 B‬, it has increased by 5.76% over the last week.
Yes, you can track Ionis Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Ionis Pharmaceuticals, Inc. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
ISI earnings for the last quarter are 0.59 EUR per share, whereas the estimation was −0.08 EUR resulting in a 868.38% surprise. The estimated earnings for the next quarter are −1.04 EUR per share. See more details about Ionis Pharmaceuticals, Inc. earnings.
Ionis Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪383.70 M‬ EUR, despite the estimated figure of ‪253.23 M‬ EUR. In the next quarter, revenue is expected to reach ‪111.34 M‬ EUR.
ISI net income for the last quarter is ‪104.88 M‬ EUR, while the quarter before that showed ‪−135.82 M‬ EUR of net income which accounts for 177.22% change. Track more Ionis Pharmaceuticals, Inc. financial stats to get the full picture.
No, ISI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 14, 2025, the company has ‪1.07 K‬ employees. See our rating of the largest employees — is Ionis Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ionis Pharmaceuticals, Inc. EBITDA is ‪−207.21 M‬ EUR, and current EBITDA margin is −64.26%. See more stats in Ionis Pharmaceuticals, Inc. financial statements.
Like other stocks, ISI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ionis Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ionis Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ionis Pharmaceuticals, Inc. stock shows the strong buy signal. See more of Ionis Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.